FOLH1 and neoplasm: The dose-dependent tumor growth inhibition of [67Cu]Cu-Sar-bisPSMA was comparable to [177Lu]Lu-PSMA I&T (5 MBq: 58 vs. 65%, 30 MBq: 109 vs. 107% against vehicle control).